{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:02:44Z","timestamp":1787137364019,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1245\/s10434-021-10724-5","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T19:02:46Z","timestamp":1637002966000},"page":"274-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Symptomatic Recurrence and Survival Outcomes After Curative Treatment of Gastric Cancer: Does Intensive Follow-up Evaluation Improve Survival?"],"prefix":"10.1245","volume":"29","author":[{"given":"Thiago Pereira","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Wilson L.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Couto","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Hugo F.","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago C.","family":"Felismino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio Melo","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ber S. C.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro L.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Lu\u00eds","family":"de Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Correia","family":"de Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Dias-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paula","family":"Curado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe J. F.","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"10724_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12885-016-2145-0","volume":"16","author":"SY Moorcraft","year":"2016","unstructured":"Moorcraft SY, Fontana E, Cunningham D, et al. Characterising timing and pattern of relapse following surgery for localized esophagogastric adenocarcinoma: a retrospective study. BMC Cancer. 2016;16:112.","journal-title":"BMC Cancer"},{"key":"10724_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12029-014-9601-3","volume":"45","author":"RD Peixoto","year":"2014","unstructured":"Peixoto RD, Lim HJ, Kim H, Abdullah A, Cheung WY. Patterns of surveillance following curative intent therapy for gastroesophageal cancer. J Gastrointest Cancer. 2014;45:325\u201333.","journal-title":"J Gastrointest Cancer."},{"key":"10724_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/bjs.4164","volume":"90","author":"F Roviello","year":"2003","unstructured":"Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113\u20139.","journal-title":"Br J Surg."},{"key":"10724_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER-2-positive advanced gastric or gastroesophageal junction cancer (ToGA): a phase 3, open-label, randomized, controlled trial. Lancet. 2010;376:687\u201397.","journal-title":"Lancet."},{"key":"10724_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/bjs.9684","volume":"102","author":"T Kinoshita","year":"2015","unstructured":"Kinoshita T, Kinoshita T, Saiura A, et al. Multicenter analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg. 2015;102:102\u20137.","journal-title":"Br J Surg"},{"key":"10724_CR6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/jama.1994.03510440047031","volume":"271","author":"The GIVIO Investigators","year":"1994","unstructured":"The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271:1587\u201392.","journal-title":"JAMA"},{"key":"10724_CR7","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1001\/jama.2018.5623","volume":"319","author":"P Wille-J\u00f8rgensen","year":"2018","unstructured":"Wille-J\u00f8rgensen P, Syk I, Smedh K, et al. Effect of more vs less frequent follow-up testing on overall and colorectal cancer\u2013specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. JAMA. 2018;319:2095\u2013103. https:\/\/doi.org\/10.1001\/jama.2018.5623.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10724_CR8","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1007\/s10120-012-0142-9","volume":"15","author":"R Cardoso","year":"2012","unstructured":"Cardoso R, Coburn NG, Seevaratnam R, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer. 2012;15(Suppl 1):S164\u20137. https:\/\/doi.org\/10.1007\/s10120-012-0142-9.","journal-title":"Gastric Cancer"},{"key":"10724_CR9","unstructured":"National Comprehensive Cancer Network. Retrieved 15 January 2017 at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.<PUB1>"},{"issue":"Suppl 5","key":"10724_CR10","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. ESMO guidelines committee. Ann Oncol. 2016;27(Suppl 5):v38\u201349.","journal-title":"Ann Oncol."},{"key":"10724_CR11","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th ed).\u00a0Gastric Cancer. 2020; https:\/\/doi.org\/10.1007\/s10120-020-01042-y. doi:https:\/\/doi.org\/10.1007\/s10120-020-01042-y. Published online ahead of print 14 February 2020.","DOI":"10.1007\/s10120-020-01042-y 10.1007\/s10120-020-01042-y"},{"key":"10724_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectablegastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"key":"10724_CR13","volume-title":"TNM classification of malignant tumours","author":"J Brierley","year":"2017","unstructured":"Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th edn. Hoboken: Wiley; 2017.","edition":"8"},{"key":"10724_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma, an attempt at a histo-clinicalclassification. Acta ParholMicrob Scan. 1965;64:31\u201349.","journal-title":"Acta ParholMicrob Scan"},{"key":"10724_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"key":"10724_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","volume":"17","author":"H Shimada","year":"2014","unstructured":"Shimada H, Noie T, Ohashi M, et al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of the literature by the Japanese Gastric Cancer Association Task Force. Gastric Cancer. 2014;17:26\u201333. https:\/\/doi.org\/10.1007\/s10120-013-0259-5.","journal-title":"Gastric Cancer"},{"key":"10724_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/annonc\/mdu543","volume":"26","author":"S Pita-Fern\u00e1ndez","year":"2015","unstructured":"Pita-Fern\u00e1ndez S, Alhayek-A\u00ed M, Gonz\u00e1lez-Mart\u00edn C, L\u00f3pez-Calvi\u00f1o B, Seoane-Pillado T, P\u00e9rtega-D\u00edaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015;26:644\u201356. https:\/\/doi.org\/10.1093\/annonc\/mdu543.","journal-title":"Ann Oncol."},{"key":"10724_CR18","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/cam4.2948","volume":"9","author":"DM Jiang","year":"2020","unstructured":"Jiang DM, Suzuki C, Espin-Garcia O, et al. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma. Cancer Med. 2020;9:3023\u201332. https:\/\/doi.org\/10.1002\/cam4.2948.","journal-title":"Cancer Med."},{"key":"10724_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3760\/cma.j.issn.0254-6450.2018.05.032","volume":"39","author":"N Zhang","year":"2018","unstructured":"Zhang N, Liu HX, Kang DM, Wang N. [Lead time bias and its control in observational studies for clinical outcomes]. Zhonghua Liu Xing Bing XueZaZhi. 2018;39:700\u20133. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2018.05.032 (PMID: 29860822 (in Chinese)).","journal-title":"Zhonghua Liu Xing Bing XueZaZhi."},{"key":"10724_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/jso.20823","volume":"96","author":"IT Tan","year":"2007","unstructured":"Tan IT, So BY. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol. 2007;96:503\u20136. https:\/\/doi.org\/10.1002\/jso.20823.","journal-title":"J Surg Oncol."},{"key":"10724_CR21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/aso.2003.12.009","volume":"10","author":"Y Kodera","year":"2003","unstructured":"Kodera Y, Ito S, Yamamura Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10:898\u2013902. https:\/\/doi.org\/10.1245\/aso.2003.12.009.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 1","key":"10724_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10120-016-0661-x","volume":"20","author":"K Fujiya","year":"2017","unstructured":"Fujiya K, Tokunaga M, Makuuchi R, et al. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer. Gastric Cancer. 2017;20(Suppl 1):141\u20139. https:\/\/doi.org\/10.1007\/s10120-016-0661-x.","journal-title":"Gastric Cancer."},{"key":"10724_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13304-018-0524-6","volume":"70","author":"D Zanotti","year":"2018","unstructured":"Zanotti D, Baiocchi GL, Coniglio A, Mohammadi B, Ministrini S, Mughal M, et al. Follow-up after surgery for gastric cancer: how to do it. Updates Surg. 2018;70:293\u20139. https:\/\/doi.org\/10.1007\/s13304-018-0524-6 (PMID: 29582358).","journal-title":"Updates Surg."},{"key":"10724_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10120-017-0738-1","volume":"21","author":"K Yamaguchi","year":"2018","unstructured":"Yamaguchi K, Yoshida K, Tanahashi T, Takahashi T, Matsuhashi N, Tanaka Y, et al. The long-term survival of stage IV gastric cancer patients with conversion therapy. Gastric Cancer. 2018;21:315\u201323. https:\/\/doi.org\/10.1007\/s10120-017-0738-1.","journal-title":"Gastric Cancer"},{"key":"10724_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","volume":"3","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3:1237\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0515.","journal-title":"JAMA Oncol."},{"key":"10724_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","volume":"17","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Goetze TO, Mueller DW, et al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase III trial of the German AIO\/CAO-V\/CAOGI. BMC Cancer. 2017;17:893. https:\/\/doi.org\/10.1186\/s12885-017-3918-9.","journal-title":"BMC Cancer."},{"key":"10724_CR27","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:2461\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(17)31827-5 (PMID: 28993052).","journal-title":"Lancet."},{"key":"10724_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. (ToGA trial investigators). Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(10)61121-X (Epub 19 August 2010. Erratum in Lancet. 2010;376:1302. PMID: 20728210).","journal-title":"Lancet."},{"key":"10724_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2 (Epub 5 June 2021 PMID: 34102137).","journal-title":"Lancet."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10724-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T18:21:13Z","timestamp":1639678873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10724-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10724"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10724-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"31 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}